Details for Patent: 5,849,752

Summary for Patent: 5,849,752

Title:	Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
Abstract:	The invention relates to the new monohydrate of 1-cyclopropyl-7-( S,S!-2,8-diazabicyclo- 4.3.0!non-8-yl)6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride (CDCH), a process for its preparation and pharmaceutical formulations which comprise this monohydrate as the active compound.
Inventor(s):	Alfons Grunenberg, Patrick Bosche
Assignee:	Bayer Intellectual Property GmbH
Application Number:	US08/760,543
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 5,849,752

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,849,752

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	195 46 249.1	Dec 12, 1995

International Family Members for US Patent 5,849,752

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0780390		PA2004012,C0780390	Lithuania
European Patent Office	0780390		PA2004012	Lithuania
Argentina	005009